NEW YORK (
CHANGE IN RATINGS
upgraded at UBS from Neutral to Buy. $33 price target. Company has strong demand drivers and can boost its margins.
(EW - Get Report)
rated new Hold at Brean Murray. Valuation call.
(FIG - Get Report)
upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. Compensation picture is becoming clearer and the company boosted its dividend. $7 price target.
(GIS - Get Report)
rated new Hold at Jefferies. $40 price target. Company lacks significant near-term catalysts.
(HOLX - Get Report)
rated new Hold at Brean Murray. Business appears to have stabilized.
Johnson & Johnson
rated new Buy at Brean Murray. $77 price target. Earnings growth could finally begin to reaccelerate.
rated new Underperform at Jefferies. $47 price target. Valuation call, as the company is investing more in future growth.
rated new Buy at Jefferies. Company can deliver above-average growth, aided by exposure to the emerging markets.
rated new Buy at Brean Murray. $44 price target. Consensus earnings expectations remain too low.
(NTAP - Get Report)
upgraded at Credit Suisse from Neutral to Outperform. Storage market has secular growth and the company can gain market share. $62 price target.
(SWFT - Get Report)
upgraded at JP Morgan to Overweight. Stock has pulled back over the past two months and offers compelling value at current levels. $16 price target.
(TTMI - Get Report)
upgraded at UBS from Neutral to Buy. $20 price target. Company is exposed to AAPL and continued smartphone demand.
End of report.